Ventyx Biosciences, Inc. - Common stock, par value $0.0001 per share (VTYX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2021 to Q4 2025

Type / Class
Equity / Common stock, par value $0.0001 per share
Symbol
VTYX on Nasdaq
Shares outstanding
71,085,776
Price per share
$9.03
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
43,853,431
Total reported value
$136,378,109
% of total 13F portfolios
0%
Share change
-559,691
Value change
-$468,454
Number of holders
109
Price from insider filings
$9.03
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Ventyx Biosciences, Inc. - Common stock, par value $0.0001 per share (VTYX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
NSV Investments I, L.P. 7.6% $5,099,900 5,425,425 Somasundaram Subramaniam 10 Mar 2025
Mohan Raju 6% 0% $39,622,962 +$48,060 4,387,682 +0.12% Raju Mohan 07 Jan 2026
Subramaniam Somu 5.8% $37,232,526 4,122,975 Subramaniam Somu 07 Jan 2026
NSV Partners III LP 5.7% $3,844,576 4,089,975 Subramaniam Somu 28 Mar 2025
Affinity Asset Advisors, LLC 5.7% $4,909,097 4,057,105 Affinity Healthcare Fund, LP 22 May 2025
VANGUARD GROUP INC 5.3% $11,725,822 3,769,997 The Vanguard Group 30 Sep 2025
Point72 Asset Management, L.P. 4.5% -48% $9,982,638 -$8,352,206 3,209,645 -46% Point72 Asset Management, L.P. 30 Sep 2025
Sio Capital Management, LLC 3.6% -35% $2,427,696 -$1,376,293 2,582,655 -36% Sio Capital Management, LLC 31 Mar 2025
CITADEL ADVISORS LLC 2% $1,325,025 1,409,601 Kenneth Griffin 31 Mar 2025
BlackRock, Inc. 1.9% $1,634,694 1,350,987 BlackRock, Inc. 30 Jun 2025
BANK OF AMERICA CORP /DE/ 1.4% -73% $955,650 -$3,383,894 1,016,649 -78% BANK OF AMERICA CORP /DE/ 31 Mar 2025
Flynn James E 0.76% $502,653 534,737 Deerfield Mgmt, L.P. 31 Dec 2024

As of 30 Sep 2025, 109 institutional investors reported holding 43,853,431 shares of Ventyx Biosciences, Inc. - Common stock, par value $0.0001 per share (VTYX). This represents 62% of the company’s total 71,085,776 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Ventyx Biosciences, Inc. - Common stock, par value $0.0001 per share (VTYX) together control 50% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Affinity Asset Advisors, LLC 5.5% 3,924,415 -13% 1.1% $12,204,931
VANGUARD GROUP INC 5.3% 3,769,997 +19% 0% $11,724,691
Point72 Asset Management, L.P. 4.5% 3,209,645 -46% 0.02% $9,981,996
TANG CAPITAL MANAGEMENT LLC 4.4% 3,100,000 0% 0.37% $9,641,000
MARSHALL WACE, LLP 3.3% 2,316,275 -3.4% 0.01% $7,203,615
Vestal Point Capital, LP 2.9% 2,050,000 +2.5% 0.29% $6,375,500
CITADEL ADVISORS LLC 2.6% 1,879,989 +6.5% 0% $5,846,766
MILLENNIUM MANAGEMENT LLC 2.3% 1,651,794 +18% 0% $5,137,079
Ikarian Capital, LLC 1.8% 1,309,604 +35% 0.92% $4,072,869
BlackRock, Inc. 1.7% 1,183,240 -14% 0% $3,679,877
SECTORAL ASSET MANAGEMENT INC 1.6% 1,107,267 +19% 2.1% $3,443,600
Redmile Group, LLC 1.5% 1,073,386 -3.7% 0.32% $3,338,230
Connor, Clark & Lunn Investment Management Ltd. 1.5% 1,059,823 +12% 0.01% $3,296,050
BAKER BROS. ADVISORS LP 1.4% 1,023,130 0.02% $3,181,934
683 Capital Management, LLC 1.4% 1,000,000 0.28% $3,110,000
Sio Capital Management, LLC 1.2% 829,178 -37% 0.65% $2,578,744
JPMORGAN CHASE & CO 1.1% 748,088 +63% 0% $2,326,554
GEODE CAPITAL MANAGEMENT, LLC 1% 728,720 +2.4% 0% $2,267,093
ACADIAN ASSET MANAGEMENT LLC 0.99% 703,800 +14% 0% $2,184,000
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.96% 679,978 +40% 0% $2,114,732
BANK OF AMERICA CORP /DE/ 0.74% 529,249 -37% 0% $1,645,965
UBS Group AG 0.74% 527,292 +43% 0% $1,639,878
D. E. Shaw & Co., Inc. 0.74% 522,688 +968% 0% $1,625,560
SPHERA FUNDS MANAGEMENT LTD. 0.62% 440,114 -21% 0.32% $1,368,755
TWO SIGMA INVESTMENTS, LP 0.61% 436,082 0% $1,356,215

Institutional Holders of Ventyx Biosciences, Inc. - Common stock, par value $0.0001 per share (VTYX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 2,261 $20,417 -$24,554 $9.03 6
2025 Q3 43,853,431 $136,378,109 -$468,454 $3.11 109
2025 Q2 44,427,101 $95,066,026 +$2,059,795 $2.14 112
2025 Q1 44,413,797 $51,071,452 -$13,704,516 $1.15 116
2024 Q4 54,449,340 $119,241,978 +$4,099,062 $2.19 122
2024 Q3 52,481,458 $114,411,465 -$11,847,683 $2.18 115
2024 Q2 56,948,057 $131,550,534 -$36,608,219 $2.31 113
2024 Q1 58,989,053 $323,841,708 +$115,160,769 $5.50 121
2023 Q4 48,012 $118,589 -$210,724 $2.47 2
2023 Q3 54,353,293 $1,887,697,915 +$49,423,641 $34.73 135
2023 Q2 52,627,413 $1,726,219,271 +$92,781,774 $32.80 146
2023 Q1 49,748,691 $1,666,552,132 +$240,845,778 $33.50 143
2022 Q4 42,342,620 $1,388,409,019 +$101,451,218 $32.79 121
2022 Q3 39,207,493 $1,367,895,289 +$165,003,180 $34.91 101
2022 Q2 34,611,539 $423,293,800 +$16,826,285 $12.23 57
2022 Q1 33,224,016 $448,316,000 +$21,697,973 $13.57 50
2021 Q4 31,606,095 $619,262,000 +$601,183,229 $19.86 46